뉴스벤징가
European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent Indication
· 발표
기사 요약
Sanofi withdrew its Dupixent application for bullous pemphigoid on June 24, 2026, due to unresolved clinical trial limitations.
기사 원문에서 발췌했어요.Sanofi withdrew its Dupixent application for bullous pemphigoid on June 24, 2026, due to unresolved clinical trial limitations.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…